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DIAGNOSTIC PERFORMANCE OF LIPID ACCUMULATION INDICES
AND TRIGLYCERIDE AND GLUCOSE INDEX FOR METABOLIC
SYNDROME IN A SAMPLE OF PERUVIAN ADULT POPULATION
RENDIMIENTO DIAGNÓSTICO DE LOS ÍNDICES DE ACUMULACIÓN LIPÍDICA Y EL ÍNDICE TRIGLICÉRIDOS
Y GLUCOSA PARA SÍNDROME METABÓLICO EN UNA MUESTRA DE POBLADORES ADULTOS PERUANOS
Jesús E. Talavera 1,3, Jenny Raquel Torres-Malca 2

ABSTRACT
Objectives: To determine the diagnostic performance of the lipid accumulation product (LAP), visceral
adiposity index (VAI), triglyceride and glucose index (TyG) and body mass index (BMI) for metabolic syndrome
(MetS) in a sample of Peruvian adults. Methods: Study of diagnostic tests of the “National Survey on
Nutritional, Biochemical, Socioeconomic, and Cultural Indicators related with Chronic Degenerative
Diseases”. An analysis of ROC curves (Receptor Operation) was made, and their respective area under the
curve (AUC) obtaining the diﬀerent parameters such as sensitivity (Sens) and speci city (Spe). It was strati ed
according to sex and according to age. To choose the cut-oﬀ point, the Youden index was used. Results: The
LAP had the highest AUC in both men (AUC = 0.929; cut-oﬀ value = 59.85; Sens = 91.6 and Spe = 84.5) and for
women (AUC = 0.950; cut-oﬀ value = 53, 06; Sens = 92.4 and Spe = 86.4). The second place, in the case of men,
was occupied by the VAI (AUC = 0.905; cut-oﬀ value = 2.36; Sens = 91.6 and Spe = 79.7), while in the case of
women it was the TyG (AUC = 0.914; cut-oﬀ value = 8.70; Sens = 87.4 and Spe = 87.3). The LAP index showed
signi cant diﬀerences with VAI to predict MetS (p <0.05), while no diﬀerences were shown with TyG.
Conclusion: The LAP index had the best diagnostic performance for MetS, both for men and women,
regardless of age.
Keywords: Metabolic syndrome, triglycerides, glucose, product of lipid accumulation, body mass index
(Source: MeSH NLM)

RESUMEN
Objetivos: Determinar el rendimiento diagnóstico del producto de acumulación de lípidos (LAP), índice de
adiposidad visceral (VAI), índice de triglicéridos y glucosa (TyG) e índice de masa corporal (IMC) para síndrome
metabólico (SMet) en una muestra de adultos peruanos. Metodología: Estudio de pruebas diagnósticas de la
“Encuesta Nacional de Indicadores Nutricionales, Bioquímicos, Socioeconómicos y Culturales relacionados
con las Enfermedades Crónicas-Degenerativas”. Se hizo un análisis de curvas ROC (Operativa del Receptor), y
su respectiva área bajo la curva (AUC) obteniendo los diferentes parámetros como sensibilidad (Sens) y
especi cidad (Esp). Se estrati có según sexo y según la edad. Para escoger el punto de corte se utilizó el índice
de Youden. Resultados: El LAP tuvo el mayor AUC tanto en hombres (AUC = 0,929; valor de corte = 59,85; Sens
= 91,6 y Esp = 84,5) como para mujeres (AUC = 0,950; valor de corte = 53,06; Sens = 92,4 y Esp = 86,4). El
segundo lugar, en el caso de los hombres, lo ocupó el VAI (AUC = 0,905; valor de corte = 2,36; Sens = 91,6 y Esp
= 79,7), mientras que en el caso de las mujeres lo fue el TyG (AUC = 0,914; valor de corte = 8,70; Sens = 87,4 y Esp
= 87,3). El índice LAP mostró diferencias signi cativas con VAI para predecir SMet (p < 0,05), mientras que no
se mostraron diferencias con TyG. Conclusión: El índice LAP tuvo el mejor rendimiento diagnóstico para
SMet, tanto a hombres y mujeres, independiente de la edad.
Palabras clave: Síndrome metabólico, triglicéridos, glucosa, producto de la acumulación de lípidos, índice de
masa corporal (Fuente DeCS BIREME)
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INTRODUCTION

hypertension.

Metabolic syndrome (SMet) is a clinical state that
includes central obesity, hypertension, hyperglycemia,

Study population

and dyslipidemia. The presence of SMet long term

The original study was carried out nationally, divided

increases the risk of developing cardiovascular disease

into ve areas: Metropolitan Lima, the remainder of the
Coast, Urban Mountains, Rural Mountains and Jungle. It

and diabetes mellitus (1,2) .

was composed of everyone above or equal to 20 years

The prevalence in the world of SMet varies. In China,
around 32.4% is found (3) , while in the United States it is
34.7 (4) . In Latin America, a systemic revision reported a

of age, that resided in that location at the time of the
survey.
The NSNBSCI had a multistage design. Clusters were

prevalence of 24.9%, more frequent among women

selected in each level, by simple random sample, and

than men (5) . In Peru, a consensus does not exist (6) ,

within each one, blocks, houses, and people were

prevalence levels uctuating between 20 to 47%(7,9) .

selected. The sample unit was the housing of clusters,
and the unit of analysis was the people with the

Smet diagnosis is not complex, but we don’t always

beforementioned charac ter istics. Additional

have the ve criteria at hand, even more so in low-

information about selection criteria, sample size and all

income areas (10). For this reason, it is important to nd

variables that were taken have been published

simpler indicators to detect SMet. The ones that have

elsewhere(22) .

shown a good diagnostic performance are triglyceride

In this study we included only the subjects who had the

and glucose index (TyG)(11,14) , and the lipid accumulation
indices, such as lipid accumulation product (LAP) and
visceral adiposity index (VAI). Body mass index (BMI) has
also been studied(15,18) .

complete data on variables of interest, and whose
laboratory or anthropometric values were within the
biologically plausible lower limits.

Variables and measures
The main variable for the diagnosis was Smet. We

These indicators have shown diﬀerent cutting points

considered SMet through the criteria of the National

and predictive capacity according to location where

Education Program on Cholesterol Adult Treatment Panel

research took place(13,19,21) . For this reason, the objective

III (ATPIII) Programa Nacional de Educación sobre el

of this study is to determine the diagnostic

Colesterol Panel de Tratamiento de Adultos III (ATPIII) (23) .

performance of LAP, VAI, TyG and BMI for SMet

In the case of ATPIII, SMet is diagnosed by presenting

con rmed in a sample of adult Peruvian inhabitants.

three or more of the following alterations: abdominal
obesity obtained with the abdominal circumference

METHODOLOGY

(AC) ≥ 88 cm for women or ≥ 102 cm for men;

Experimental design

hypertriglyceridemia (triglycerides ≥ 150 mg/dl);

Diagnostic test studies. Data base analysis secondary to

hyperglycemia (fasting glucose ≥ 100 mg/dl or if they

“National Sur vey on Nutritional, Biochemical,

receive treatment to lower glucose levels); high blood

Socioeconomic, and Cultural Indicators related with
Chronic Degenerative Diseases” (NSNBSCI), performed
between the years 2004 – 2005 (22) . The purpose of this
survey was to learn the prevalence of chronic diseases
of metabolic origin, such as metabolic syndrome, lipid
disorders, type 2 diabetes mellitus,
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and arterial

pressure (systolic blood pressure ≥ 130 mmHg or
diastolic blood pressure ≥ 85 mmHg or receive
treatment to lower blood pressure levels); low HDL
(HDL-cholesterol < 50 mg/dl in women or < 40 mg/dl in
men).
There were four variables considered to test their
diagnostic performance (Table 1):

2
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Table 1. Predictive equations to calculate metabolic syndrome
Index

Equation

BMI*

Weight (Kg) / height2 (meters)

TyG**

Ln (TG [mg/dL] x fasting glucose (mg/dL)/2)

VAI***

Men
Women
(AC/[36.58 + (1.89 x BMI)]) x
(AC/[39.68 + (1.88 x BMI)]) x (triglycerides/1.03) x
(triglycerides/0.81) x (1.52/HDL-cholesterol)
(1.31/HDL-cholesterol)

LAP****

Men
(AC - 65) x TG

Women
(AC - 58) x TG

*Body Mass Index, **Triglyceride and Glucose index, ***Visceral adiposity index, ****Lipid Accumulation Product

AC values lower than 65 and 58 cm in women and men
were reassigned to 66 and 59 cm, in order to avoid
invalid data. For VAI and LAP, TG and HDL in mmol/L
were presented. The other variables included in the
study were age (in years), body mass index (BMI),
smoker state (if they have ever smoked “yes” or “no”),
alcohol drinker (if they have ever had an alcoholic drink
“yes” or ”no”), and physical activity (do you practice
physical activity outside of your work “yes” or “no”).
In NSNBSCI, the anthropometric measures were
obtained using a mobile wooden measure and a
standing digital balance of Sohenle Brand with 120 kg
capacity and speci city of 0.1 kg. Once the weight and
height are obtained, we proceeded to calculate BMI
applying the corresponding formula: Weight (kg)
/Height2 (m). The waist perimeter was measured with a
exible measuring tape at the middle point between
the lower edge of the ribs and the iliac crest, passing by
the half centimeter closest to the navel. The blood
pressure measures were performed using a Mac-Check501 sphygmomanometer.
The subject was asked to have a minimum fasting of 8
hours to obtain the biochemical samples. The blood
samples were taken through a vacuum system with a
gel clot activator. We obtained the blood using
Handzentrifuge manual centrifuges of 3000 RPM and
cr yovials that allowed the safe transfer and
conservation of the samples. Glucose was obtained
based on an enzymatic Trinder-GOD-PAD (glucose
oxidase) method, and HDL-cholesterol was obtained
through an enzymatic Trinder-Colorimetric method.

Statistical analysis
STATA v16.0 statistical software was used. For this
analysis, we strati ed according to sex. In the bivariate

analysis, considering the SMet outcome, Chi square
teste of independence was used for the categorical
covariables, while the Mann Whitney U-test for the
numerical covariables, since they did not present
normal distribution, which was evaluated through bias,
kurtosis, and histogram.
In order to evaluate the discriminative diagnostic
performance, we used ROC curve analysis (Receiver
Operating Characteristic) and its respective area under
the curve (AUC) as statistical and graphic method. We
calculated sensitivity (Sens), speci city (Spec), positive
(PPV) and negative predictive value (NPV) and positive
(LR+) and negative likelihood ratio (LR-). Youden’s index
was used to determine the optimal cut oﬀ point. The
ROC curve was graphed according to sex and age
younger and older equal to 65 years.

Ethical considerations
This is a secondary analysis of the database with free
public access. At the same time, the base is codi ed,
guaranteeing the con dentiality and anonymity of the
participants. Therefore, the damage to these subject is
minimal.

RESULTS
We worked with a total of 1936 men and 2055 women.
Of the total, 24,33% presented SMet, as opposed to men
which was only 5.53%. The average age of men with
Smet was greater than the age of women. There were no
diﬀerences between both sexes compared to having
smoked before and presenting Smet. However, for
women, we found an association between presenting
Smet and having ever drank alcohol, but not in men. The
rest of the comparisons, which were statistically
signi cant, are found in Table 2.
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Table 2. Table 2. Comparisons between clinical and biochemical characteristics according to
sex and presence of Metabolic Syndrome. MetS: Metabolic Syndrome, TyG: Triglycerides and
Glucose indices, LAP: Lipid Accumulation Products and VAI: Visceral Adipose Index
Masculine (n = 1936)

Characteris cs

MetS (-)

MetS (+)

Feminine (n = 2055)
P-value

MetS (-)

MetS (+)

P-value

Total (%)
Age (years)
Body Mass Index (Kg/m2)
Smoking status (%)
No
Yes
Alcohol drinking (%)
No
Yes
Physical Activity (%)
No
Yes
Abdominal waist (cm)
Systolic blood pressure (mmHg)
Diastolic blood pressure
(mmHg)
Glucose (mg/dl)
Triglycerides (mg/dl)
HDL - cholesterol (mg/dl)
MetS parameters
LAP
VAI
TyG
MetS Components
Central obesity (%)
No
Yes
High blood pressure (%)
No
Yes
Hyperglycemia (%)
No
Yes
Hypertriglyceridemia (%)
No
yes
Low HDL - cholesterol (%)
No
Yes

Numeric values are presented in median and interquartile range

With relation to ROC analysis and AUC of the 4 indices

= 91.6 and Spec = 79.7), while for women, it was TyG (AUC

tested for the identi cation of SMet, for both men and

= 0.914; cut-oﬀ point = 8.70; Sens = 87.4 and Spec = 87.3).

women, LAP had the highest AUC for men (AUC = 0.929;

The LAP index showed signi cant diﬀerences with VAI to

cut-oﬀ point = 59.85; Sens = 91.6 and Spec = 84.5) as for

predict SMet (p < 0,05), while no diﬀerences were found

women (AUC = 0.950; cut-oﬀ point = 53.06; Sens = 92.4

with TyG. The rest of data are found in Table 3.

and Spec = 86.4). In second place, for men, VAI index had
the highest AUC (AUC = 0.905; cut-oﬀ point = 2.36; Sens
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Figure 1 graphs AUC according to sex and age.
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Figure 1. Diagnostic value comparison between triglyceride and glucose (TyG), Lipid accumulation product (LAP), and visceral
adipose index (VAI) for metabolic syndrome in (a) men, (b) women, (c ) under 65 years of age, and (d) over 65 years of age.

Table 3. Diagnostic values of TyG, LAP and VAI in men and women with metabolic syndrome.
Masculine

Cut-oﬀ
point

Sens %* (CI 95%)

Spec % *(CI 95%)

PPV%* (Ci95%) NPV %* (CI 95%)

LR+ %* (CI 95%)

LR- %* (CI 95%)

IY*

Feminine
VAI**
LAP**
TyG**
BMI**

*AUC: area under the curve, Sens: sensitivity, Spec: speci city, PPV: positive predictive value, NPV: negative predictive value,
LR+: Positive likelihood ratio, LR-: Negative likelihood ratio and YI: Youden's Index
CI 95%: Con dence interval at 95%
** VAI: visceral adipose index, LAP: lipid accumulation product, TyG: triglyceride and glucose index and BMI: body mass index
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DISCUSSION
Principle ﬁndings
With the objective of nding a better indicator to
predict SMet, this study evaluated BMI, LAP< VAI, TyG
indices in a sample of adult Peruvian inhabitants. In
general, we found that LAP, followed by TyG, were
practical parameters to identify SMet, for both men and
women and independent of age.

Comparison with other studies
LAP was mentioned rst by Khan (24) , where it was
considered an excessive marker of lipid accumulation in
adults, and very useful for predicting SMet (25) . In the
current manuscript, LAP was considered the best
indicator for predicting SMet, for their AUC as for their
sensitivity and speci city values. These results coincide
with some others found in literature. The study by
Chiang and Koo (19) found that LAP was a better SMet
predictor than VAI and TyG in Thai adults older than 50
years of age, with a cut-oﬀ point of 31.6 and with a
sensitivity of 88% and 60% for men and women,
respectively. In another study carried out by Spaniards(26)
they found the same regarding LAP with cut-oﬀ points
of 51.82 and 48.09 with sensitivity of 81 % and 78 % for
men and women, respectively. In the work by Kyung-A y
Young-Joo (16) ., LAP values were the best predictors of
SMet.
The diﬀerence with the cut-oﬀ points with the current
manuscript could be due to ethnic and biomarker
frequency diﬀerences that make up LAP and SMet. In
the study of 522 healthy Argentinians, by Tellechea (27) ,
the LAP cut-oﬀ point 53.63 demonstrated the greatest
precise diagnosis for SMet, with a sensitivity of 0.83 and
speci city of 0.83. In a study in Brazil, although the cutoﬀ points were diﬀerent, we must take into account that
they used criteria diﬀerent than ATPIII(20) .
VAI is an important indicator related in an important
manner with Smet (28) . In this study, LAP occupied
second place as a diagnostic predictor of SMet in men,
and third in women, behind TyG. This diﬀers from other
research works. In a study of Iranian population of 35-65
year-olds, Baveicy et al (21) found that VAI had a greater
predictive value for SMet than other biomarkers. The
same found in the study by Stefanescu et al (29) ., who
worked with Peruvian inhabitants, residents of Callao.
However, LAP was not considered among its variables,
and it was only a localized population. The same was
found with respect to VAI in the study by Motamed et al(30) .
The ethnic and dietary reasons may be involved.
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Regarding TyG, no diﬀerences were found with AUC.
However, LAP sensitivity and speci city values are
better balanced than those of TyG, being more useful
the rst as a diagnostic test.
Nevertheless, we must consider its role in SMet.
Although TyG was studied at rst as a predictor of RI (31) ,
later studies have considered it as an SMet marker. In
the study by Kyung-A and Young-Joo (16) , TyG values
increased as SMet component numbers increased.
Aslan Çin et al (11) . and Anggonari (13) highlight its SMet
diagnostic value in adolescents. On the other hand, the
cut-oﬀ point for this study diﬀered for men (8.77) as for
women (8.70), which diﬀer from other works such as Li
et al (32) , who gave a cut-oﬀ point of 8.81; or in the study
by Moon (14) ., who reported a cut-oﬀ of 8.45. Reasons
why TyG index may not be the best indicator for SMet
are that, although it includes glucose and triglycerides,
it does not include AC, which some authors consider it
as the most important SMet marker(33) .
Regarding BMI, it demonstrated the least SMet
diagnostic capacity for both sexes. A metanalysis by Lee
et al (34) . reported that BMI was the worst discriminator to
predict diabetes, hypertension, or dyslipidemia.
Herrera et al. also reported that BMI was the least
precise measure for coronary disease risk (35) . In a study
by Thai-Hua(17) , other indices, such as VAI surpassed BMI
in predicting metabolic syndrome.

Result interpretations
Among all the diﬀerent scenarios that could lead us to
SMet, one of the most important is visceral adiposity. In
several studies, it has been demonstrated that visceral
adipose tissue has a greater rate of lipolysis and a
greater production of adipocytokines, such as
interleukin-6, the inhibitor of plasminogen-1 activator
and tissue macrophage activation, which is more
related with cardiometabolic risks in comparison to
subcutaneous adipose tissue(36,37) .
At the same time, a release of free fatty acids may cause
the accumulation oﬀ at intraorganically, such as liver
and pancreas. The latter produces, ultimately, a state of
insulin resistance, increasing the hepatic production of
glucose, reduction of hepatic insulin clearance, increase
in abdominal waist, increase of circulating triglycerides,
and, nally, all which lead to SMet(38) .

Study limitations
Some limitations should be considered. First, this is a
cross-sectional study, which means we cannot evaluate
the association of these variables with SMet in a
longitudinal form. Second, the database was not
collected for the purpose of this study. Furthermore, the
survey was carried out in the years 2004-2005, which is
possible the abdominal circumference of a similar
current population may be diﬀerent. However, it is
important to consider that it oﬀers us a rst glimpse of
diagnostic performance of variables that have been
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tested. Third, while the participants are Peruvians from

with optimal cut-oﬀ points of 59.85 and 53.06,

diﬀerent regions of the country, it is probable that it is

respectively. The LAP index is easy to use and does not

not completely representative, but given the

require expensive laboratory tests, making it an easy-

characteristics that they may share in common, some
inference may be made.

to-use index in primary care compared to VAI that
requires AC, TG, BMI and HDL cholesterol for its

CONCLUSIONS

calculation. If the current results are con rmed in future

The LAP index had the greatest SMet diagnostic

research, LAP should be included as an SMet predictor

performance, for men and women, independent of age,

primary health care.
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